Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Norwich

Norwich Single-Cell and Spatial Symposium

Single-cell and spatial technologies are rapidly evolving, offering fresh insights into the complexity and diversity of cells within living systems. This symposium is designed to [...]

Go to Top